Secondary Malignant Neoplasm — Trials

Secondary Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

14,658 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,270
Recruiting: 2,317
Ph III recruiting: 269
Growth YoY: +13.3%
Industry share: 22%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,960)

clinicaltrialsPublishedShowing 5,151–5,157 of 5,157 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03351842	Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%	recruiting	Phase 2	460	Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER	1	Dec 19, 2017	clinicaltrials
NCT03368651	The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) Who Underwent Hepatectomy : A Random, Controlled, Stage III Clinical Trial.	recruiting	Phase 3	230	Sun Yat-sen UniversityOTHER	1